Vaxart (NASDAQ: VXRT) reported Q3 EPS of ($0.06), $0.04 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $4.93 million versus the consensus estimate of $1.93 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.